Los Angeles, May 8, 2019: bioQuad OsteoDenx® – popularly known as the ‘Bone and Joint Bio-replenishment’ - will available to American consumers in mid-May 2019.

Osteodenx is backed by multiple patents and is the only supplement in the market powered by Ribonuclease-enriched Lactoferrin (RELF) technology. RELF, the active complex in OsteoDenx, has undergone extensive human clinical studies. The positive health benefits of RELF are published in top-tier, peer-reviewed medical journals.

The bioQuad OsteoDenx formula also contains beneficial synergists such as collagen peptides, boswellia extract, resveratrol, bone-specific minerals (i.e. copper, manganese and selenium), and vitamins (i.e. D3, K1 and folate). It is manufactured in Europe in compliance with strict EFSA health regulations. OsteoDenx was launched in Europe in 2017 by bioQuad Europe B.V., a leading life sciences company located at the Amsterdam University Science Park. Since its launch, the product has been widely distributed in clinics, pharmacies, retail nutritional outlets throughout Europe.“Product experiences with OsteoDenx as a potent bone and joint bio-replenishment are well established among health-conscious customers and clinical practitioners”

“Product experiences with OsteoDenx as a potent bone and joint bio-replenishment are well established among health-conscious customers and clinical practitioners”, explained Dr. Sreus Naidu, Managing Director of bioQuad.

“Our patented health technology has garnered the attention of major trade journals, media, and local TV broadcasters in Europe."

"Our core competency is in medical research and health education”, Dr. Naidu emphasized.

“We travel all over the world to spread awareness in self-care to achieve healthy living. We organize webinars, produce movies and publish blogs to share our latest research developments. Our scientific credibility and business integrity with the OsteoDenx technology is reflected by its overwhelming acceptance in the healthcare system. To meet the growing consumer demand, we are manufacturing the bioQuad products at two major facilities in Belgium and The Netherlands. We are steadily expanding our operations.”“A number of health centers in Europe started recommending OsteoDenx to patients, the finest bone and joint healthcare option – a remarkable development”

“The health benefits of OsteoDenx were quickly noticed by the Dutch health practitioners,” remarked Mr. Pieter Pieters, Managing Director of ProVital, a top health nutritional distribution company in the Netherlands. “After observing an unprecedented spike in our business after partnering with the bioQuad team”, Mr. Pieters reiterated, “it was an obvious decision for our company to replace our existing bone health products with the exclusive OsteoDenx® - the next generation bone and joint bio-replenishment.”

Professor Dr. Narain Naidu is the renowned medical scientist behind the research and development of RELF technology in OsteoDenx. In 2018, Professor Naidu was invited as the keynote speaker at the ‘International Therapists Expo-Houten’, in The Netherlands. This mega European event is attended by nearly 10,000 natural health practitioners and is represented by over 300 healthcare companies. Professor Naidu’s lecture on ‘Lactoferrin and RELF’ was the highlight of this convention, proceeded by the book signing of his acclaimed medical volume - ‘Bio-replenishment for Bone Health’.

Dr. Dick Nicolai, Medical Director of the Medical Center for Natural Health in Heerenveen, commented, “Professor Naidu’s lecture at the Annual Expo-Houten showcased the therapeutic prowess of OsteoDenx and this evidence-based bone and joint bio-replenishment influenced several natural health practitioners in Holland. A number of health centers in Europe started recommending OsteoDenx to patients, as the finest bone and joint healthcare option – a remarkable development!” Dr. Nicolai and his colleagues have organized educational seminars for health practitioners throughout Holland to showcase the clinical efficacy of OsteoDenx.OsteoDenx® is certified by the ‘Informed-Sport’, a quality assurance program for sports nutrition. Every batch is tested for banned substances under this certification program.

bioQuad OsteoDenx is certified by the ‘Informed-Sport’, a quality assurance program for sports nutrition. Every batch of OsteoDenx is tested for banned substances under this certification program. OsteoDenx undergoes rigorous testing at an ISO17025 accredited lab to provide the highest level of assurance of safety for athletes to use in competitive sports.

Dr. Sreus Naidu shares, “bioQuad is known for scientific excellence in healthcare. We operate with ethical and social responsibility. We are proud to have made significant breakthroughs in biomedical sciences and to be able to introduce cutting-edge health technologies such as OsteoDenx to the global market”. In his conclusive statement, Dr. Sreus Naidu emphasized, “We are fully committed to building transparent business relationships, earning customer loyalty and paving distribution opportunities worldwide.”

OsteoDenx will be available in the United States as a Single-Pack (30-Caps) priced at MSRP $39.95 or as a cost-saving Dual-Pack (60-Caps) at MSRP $69.95.

Customers can save even more by joining the bioQuad Subscription Program. Stay tuned to learn more about bioQuad and it revolutionary health technologies.